Pneumocystis-Carinii Pneumonia in Patients with Ulcerative-Colitis Treated with Corticosteroids

Typeset version

 

TY  - JOUR
  - Bernstein, C. N.,Kolodny, M.,Block, E.,Shanahan, F.
  - 1993
  - April
  - Pneumocystis-Carinii Pneumonia in Patients with Ulcerative-Colitis Treated with Corticosteroids
  - Validated
  - ()
  - 88
  - 44
  - 574
  - 577574
  - Today, Pneumocystis carinii pneumonia (PCP) is typically associated with AIDS. However, in the pre-AIDS era, PCP was known to be associated with various immunodeficiency states, malignancies, and immunosuppressive therapy, particularly the use of corticosteroids. PCP has been reported to occur during immunosuppressive therapy of some chronic inflammatory states, but it has never been reported in patients with inflammatory bowel disease. We report two patients with ulcerative colitis who developed PCP during high-dose corticosteroid therapy, and review the literature regarding non-AIDS PCP. PCP should thus be added to the list of bronchopulmonary complications in inflammatory bowel disease. This report should give gastroenterologists further impetus to limit immunosuppressive therapy to its minimal effective dose.Today, Pneumocystis carinii pneumonia (PCP) is typically associated with AIDS. However, in the pre-AIDS era, PCP was known to be associated with various immunodeficiency states, malignancies, and immunosuppressive therapy, particularly the use of corticosteroids. PCP has been reported to occur during immunosuppressive therapy of some chronic inflammatory states, but it has never been reported in patients with inflammatory bowel disease. We report two patients with ulcerative colitis who developed PCP during high-dose corticosteroid therapy, and review the literature regarding non-AIDS PCP. PCP should thus be added to the list of bronchopulmonary complications in inflammatory bowel disease. This report should give gastroenterologists further impetus to limit immunosuppressive therapy to its minimal effective dose.
  - 0002-92700002-9270
  - ://WOS:A1993KW46300021://WOS:A1993KW46300021
DA  - 1993/04
ER  - 
@article{V235380038,
   = {Bernstein,  C. N. and Kolodny,  M. and Block,  E. and Shanahan,  F. },
   = {1993},
   = {April},
   = {Pneumocystis-Carinii Pneumonia in Patients with Ulcerative-Colitis Treated with Corticosteroids},
   = {Validated},
   = {()},
   = {88},
   = {44},
  pages = {574--577574},
   = {{Today, Pneumocystis carinii pneumonia (PCP) is typically associated with AIDS. However, in the pre-AIDS era, PCP was known to be associated with various immunodeficiency states, malignancies, and immunosuppressive therapy, particularly the use of corticosteroids. PCP has been reported to occur during immunosuppressive therapy of some chronic inflammatory states, but it has never been reported in patients with inflammatory bowel disease. We report two patients with ulcerative colitis who developed PCP during high-dose corticosteroid therapy, and review the literature regarding non-AIDS PCP. PCP should thus be added to the list of bronchopulmonary complications in inflammatory bowel disease. This report should give gastroenterologists further impetus to limit immunosuppressive therapy to its minimal effective dose.Today, Pneumocystis carinii pneumonia (PCP) is typically associated with AIDS. However, in the pre-AIDS era, PCP was known to be associated with various immunodeficiency states, malignancies, and immunosuppressive therapy, particularly the use of corticosteroids. PCP has been reported to occur during immunosuppressive therapy of some chronic inflammatory states, but it has never been reported in patients with inflammatory bowel disease. We report two patients with ulcerative colitis who developed PCP during high-dose corticosteroid therapy, and review the literature regarding non-AIDS PCP. PCP should thus be added to the list of bronchopulmonary complications in inflammatory bowel disease. This report should give gastroenterologists further impetus to limit immunosuppressive therapy to its minimal effective dose.}},
  issn = {0002-92700002-9270},
   = {://WOS:A1993KW46300021://WOS:A1993KW46300021},
  source = {IRIS}
}
AUTHORSBernstein, C. N.,Kolodny, M.,Block, E.,Shanahan, F.
YEAR1993
MONTHApril
JOURNAL_CODE
TITLEPneumocystis-Carinii Pneumonia in Patients with Ulcerative-Colitis Treated with Corticosteroids
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORD
VOLUME88
ISSUE44
START_PAGE574
END_PAGE577574
ABSTRACTToday, Pneumocystis carinii pneumonia (PCP) is typically associated with AIDS. However, in the pre-AIDS era, PCP was known to be associated with various immunodeficiency states, malignancies, and immunosuppressive therapy, particularly the use of corticosteroids. PCP has been reported to occur during immunosuppressive therapy of some chronic inflammatory states, but it has never been reported in patients with inflammatory bowel disease. We report two patients with ulcerative colitis who developed PCP during high-dose corticosteroid therapy, and review the literature regarding non-AIDS PCP. PCP should thus be added to the list of bronchopulmonary complications in inflammatory bowel disease. This report should give gastroenterologists further impetus to limit immunosuppressive therapy to its minimal effective dose.Today, Pneumocystis carinii pneumonia (PCP) is typically associated with AIDS. However, in the pre-AIDS era, PCP was known to be associated with various immunodeficiency states, malignancies, and immunosuppressive therapy, particularly the use of corticosteroids. PCP has been reported to occur during immunosuppressive therapy of some chronic inflammatory states, but it has never been reported in patients with inflammatory bowel disease. We report two patients with ulcerative colitis who developed PCP during high-dose corticosteroid therapy, and review the literature regarding non-AIDS PCP. PCP should thus be added to the list of bronchopulmonary complications in inflammatory bowel disease. This report should give gastroenterologists further impetus to limit immunosuppressive therapy to its minimal effective dose.
PUBLISHER_LOCATION
ISBN_ISSN0002-92700002-9270
EDITION
URL://WOS:A1993KW46300021://WOS:A1993KW46300021
DOI_LINK
FUNDING_BODY
GRANT_DETAILS